legit ba ang fortune gems

legit ba ang fortune gems Times News Network Ludhiana: Former sarpanch of Rano village, Payal, Gurdeep Singh Rano , who was arrested by the Anti Narcotic Task Force (ANTF) in 2020 for running an international drug syndicate, has been detained under Prevention of Illicit Traffic in Narcotic Drugs and Psychotropic Substance (PIT NDPS) Act. Gurkirat Kirpal Singh, secretary, home affairs, Punjab issued the detention order on the recommendation of ANTF. Rano applied for bail but after the detention orders, he will remain in custody for at least one year, even if his bail is granted, said an ANTF official. After the detention orders, Rano was transferred from Central Jail, Kapurthala to Central Jail, Bathinda. Officials said that the action would prove to be a milestone in efforts against drug smuggling in Punjab. During the detention period, he will only be allowed to meet family members. These meetings will be recorded. On Nov 6, 2020, the task force arrested Rano, his aides Ravej of Mahavir Colony, Iqbal Singh of Payal and Randeep Singh of Khanna. Police recovered 5.7 kg heroin, 400gm opium, 3 pistols- including two of .32 bore and one of 7.62 bore, a .32 caliber revolver, two rifles, 12 luxury cars and Rs 50.24 lakh drug money from their possession. An FIR was registered under relevant sections of the NDPS Act, Arms Act, IPC and Punjab Police Act against him at STF Mohali. During the probe, 31.418 kg heroin, 6 kg Amphetamine and 2 kg chemical powder was recovered from Rano and his accomplices. Snehdeep Sharma, AIG ANTF said that Rano had applied for bail but ANTF approached the home department. Although Rano had been lodged in jail since 2020, he tried to run the drug trade from prison, prompting ANTF to write to the govt. Sharma added that moveable and immoveable properties worth Rs 7.80 crore belonging to Rano were seized. Besides, seven more FIRs under the NDPS and other acts were registered against Gurdeep Singh. We also published the following articles recently 1-year detention for drug smuggler Gurdeep Rano under PIT NDPS act Former village head Gurdeep Singh Rano, arrested in 2020 for international drug trafficking, has been detained under the PIT NDPS Act. Despite a pending bail plea, Rano will remain in custody for at least a year. Authorities seized drugs, weapons, luxury cars, and cash during his arrest. Former Chandragiri MLA booked under POCSO Act Former Chandragiri MLA Chevireddy Bhaskar Reddy and a YSRCP convenor were booked under the POCSO Act and other laws for allegedly spreading false rumors about the rape of a minor girl. Tirupati police debunked the social media rumors and filed charges based on the girl's father's complaint, who accused them of revealing his daughter's identity and spreading misinformation. Four drug peddlers nabbed in J-K's Reasi, heroin recovered Four alleged drug traffickers were apprehended in Reasi district, Jammu and Kashmir, after heroin was discovered in their vehicle during a routine check. The suspects, identified as Anil Sharma, Shubham Singh, Vivek Raina, and Kamal Kumar, all Reasi residents, were en route from Katra when intercepted at Sula Naka.

Steady leadership, unmatched wisdom: India’s sports community mourns Dr Singh’s demiseGaetz withdraws as Trump's pick for attorney general, averting confirmation battle in the Senate WASHINGTON (AP) — Matt Gaetz has withdrawn as Donald Trump’s pick for attorney general following scrutiny over a federal sex trafficking investigation. The Florida Republican made the announcement Thursday. Gaetz’s withdrawal is a blow to Trump’s push to install steadfast loyalists in his incoming administration and the first sign that Trump could face resistance from members of his own party. Trump said in a social media post that Gaetz “did not want to be a distraction for the Administration.” Gaetz said “it is clear that my confirmation was unfairly becoming a distraction to the critical work" of the transition team. He added, “There is no time to waste on a needlessly protracted Washington scuffle.” Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Success! An email has been sent to with a link to confirm list signup. Error! There was an error processing your request. Get the latest need-to-know information delivered to your inbox as it happens. Our flagship newsletter. Get our front page stories each morning as well as the latest updates each afternoon during the week + more in-depth weekend editions on Saturdays & Sundays.

OTTAWA — NDP Leader Jagmeet Singh says his party will not support a Liberal plan to give Canadians a GST holiday and $250 unless the government expands eligibility for the cheques, saying the rebate leaves out "the most vulnerable." The Liberals announced a plan last week to cut the federal sales tax on a raft of items like toys and restaurant meals for two months, and to give $250 to more than 18.7 million Canadians in the spring. Speaking after a Canadian Labour Congress event in Ottawa, Singh says he's open to passing the GST legislation, but the rebate needs to include seniors, students, people who are on disability benefits and those who were not able to work last year. Singh says he initially supported the idea because he thought the rebate cheques would go to anyone who earned under $150,000 last year. But the so-called working Canadians rebate will be sent to those who had an income, leaving out people Singh says need the help. The government intends to include the measures in the fall economic statement, which has not yet been introduced in the House of Commons. The proposed GST holiday would begin in mid-December, lasting for two months. It would remove the GST on prepared foods at grocery stores, some alcoholic drinks, children's clothes and toys, Christmas trees, restaurant meals, books, video games and physical newspapers. A privilege debate has held up all government business in the House since late September, with the Conservatives pledging to continue a filibuster until the government hands over unredacted documents related to misspending at a green technology fund. The NDP said last week they had agreed to pause the privilege debate in order to pass the legislation to usher in the GST holiday. Singh said Tuesday that unless there are changes to the proposed legislation, he will not support pausing the debate. The Bloc Québécois is also pushing for the rebates to be sent to seniors and retirees. This report by The Canadian Press was first published Nov. 26, 2024. David Baxter, The Canadian PressLibyan Crown Prince Mohammed El Senussi Calls for Unity and Stability Amid Regional Upheaval

Commanders place kicker Austin Seibert on injured reserveBuy Smarter: The Consumer Guide to Smart TVsDavid Staples: Province finally axes Edmonton's sketchy photo radar 'fishing holes'

The Revenge of the KarenIRVINE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE TechnologyTM (SmartPath)—the industry’s first tissue-to-digitalTM imager using MUSE (Microscopy with Ultraviolet Surface Excitation) technology, intended to create a solution that eliminates the need for traditional slide-based histology, a fundamental process that has remained unchanged for over a century. SmartPath’s objective of this advanced imager is to provide new technology that rapidly captures high-resolution ultraviolet images, directly from whole fresh or formalin-fixed (non-FFPE) tissue, and convert these UV images to detailed H&E-like digital images for pathologist’s review. Utilization of non-caustic fluorescent dyes on fresh tissue significantly improves RNA retained in the sample for downstream processing. This first of its kind imager implements a simple workflow, with the goal of bringing unprecedented efficiency to aid pathologists in diagnostic pathology labs worldwide. By eliminating cumbersome manual processes, SmartPath has the potential to propel pathology into the digital age and support a wide range of global IVD applications and market segments. Matthew Nuñez, CEO of MUSE Microscopy, Inc., expressed the company’s enthusiasm about this landmark achievement: “We are immensely proud of the advancements we’ve made with SmartPath—a groundbreaking tissue-to-digital imager that redefines where true digital pathology starts. This moment signifies more than just a new product; it represents the potential for a fundamental transformation for the entire field of pathology, empowering professionals to move past legacy processes that have constrained advancements in workflow and diagnostics for far too long. With SmartPath, we are intent on setting a new standard and opening doors to the next generation of aids in pathology.” Transforming a Long-Standing Pathology Workflow The SmartPath Imager tackles one of pathology’s most persistent challenges: the dependence on traditional glass slide histology. By leveraging rapid tissue-to-digital imaging technology, SmartPath seeks to transform pathology, from analog slide-based processes to a seamless and effective workflow that provides high-resolution digital tissue images to pathologists, without destructive direct-to-digital sample preparation. The statements made regarding the SmartPath Imager have not been evaluated by the Food and Drug Administration (FDA). The SmartPath System is currently intended for research use only. This medical device has not yet been evaluated or cleared by the FDA. Its safety and effectiveness have not been established nor confirmed by FDA-approved research. SmartPath is not currently available for sale in the United States as a diagnostic aid or medical device for human pathology. This material is provided solely for informational purposes and does not substitute for professional medical advice. It also does not constitute an offer to promote the device for any medical use. About MUSE Microscopy, Inc. MUSE Microscopy, Inc. is a company that specializes in the application of Microscopy with Ultraviolet Surface Excitation (MUSE). We are developing a MUSE-enabled imaging system for diagnostic assistance in pathology, cytology, and research applications. SmartPath MUSE TechnologyTM (SmartPath), is intended to be a slide-free tissue-to-digital imaging platform that aims to revolutionize digital pathology by eliminating the need for traditional slide-based histology. Our goal is to offer a first-to-market, non-destructive tissue imaging solution. To learn more, you can visit their website at https://musemicroscopy.com/ or find them on social media platforms such as X, Facebook, and LinkedIn. Limits on Accuracy This press release is intended to provide information about MUSE Microscopy, Inc.’s research and potential product. Information is believed to be accurate at the time it is created. However, like any printed material, information may become outdated over time. Information may contain technical inaccuracies or typographical errors. Information may be changed or updated without notice. There may also be improvements or changes in the products and services described in this press release at any time without notice. It is important that you rely on the advice of an appropriate professional. Nothing contained in any presentation is to be construed as medical, legal, investment, financial, or other advice. This information is not intended to be a substitute for such advice. MUSE Microscopy, Inc. does not endorse any specific techniques or methods of treatment. Individuals are advised to consult their health care professionals for full information about the potential adverse reactions from use of the medical technologies discussed in this press release. We will use reasonable efforts to include accurate and up-to-date information on the website, but MUSE Microscopy, Inc. makes no warranties or representations as to its accuracy. Forward-Looking Statements Forward-looking statements in this press release are based on our future expectations, plans prospects, and assumptions regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. The words “termed,” “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law. CONTACT: Matthew Nuñez Tel: 949.813.6121 mnunez@musemicroscopy.com Source: MUSE Microscopy, Inc.

Buy Smarter: The Consumer Guide to Smart TVs

LeBron James is going to have to make room for the NFL . Wednesday's doubleheader on Netflix set records as the most-streamed NFL games in U.S. history, with numbers nearly five times more than the NBA . > Philadelphia news 24/7: Watch NBC10 free wherever you are The Baltimore Ra ve ns' 31-2 victory over the Houston Texans averaged 24.3 million while Kansas City's 29-10 win at Pittsburgh averaged 24.1 according to early viewer figures released by Nielsen on Thursday. Nielsen also said there were 65 million U.S. viewers who tuned in for at least one minute of one of the two games. The NBA's five-game slate averaged about 5.25 million viewers per game across ABC, ESPN and its platforms, according to the league and Nielsen. “I love the NFL,” James said in his televised postgame interview Wednesday night. “But Christmas is our day.” While the NBA's Christmas lineup has its best viewer numbers in five years, the NFL has made Christmas one of its tentpole events during the regular season, joining Kickoff Weekend and Thanksgiving. In partnership with NBC Sports Philadelphia “The numbers speak for themselves and LeBron can have his own view, and I’m sure more people will look at that because of this," said Hans Schroeder, the executive vice president of NFL Media. "But, you know, we’re focused on the NFL and we’re thrilled with the results this year with the Christmas on Netflix and we’re excited to continue to build that over the next couple of years.” Both NFL games surpassed the previous mark of 23 million for last season’s AFC wild-card game between the Miami Dolphins and Chiefs on Peacock. Viewership for Ravens-Texans peaked with the Beyoncé Bowl. The 20-minute halftime performance averaged over 27 million viewers. The viewer figures include the audience on Netflix, mobile viewership on NFL+ and those who tuned in on CBS stations in Pittsburgh, Kansas City, Baltimore and Houston. Global ratings and final U.S. numbers are expected to be available on Tuesday. The NFL's Christmas numbers decreased from last season, but not at the rate that usually happens when something goes from broadcast to streaming. Last year’s three games averaged 28.68 million viewers. The early afternoon contest between the Las Vegas Raiders and Chiefs led the way, averaging 29.48 million on CBS. Once global and Netflix's first-party data is released, both Christmas games should surpass 30 million. The NBA's lineup saw an 84% rise over 2023. One reason for the increase is that all five games were on ABC, compared to two last year. The Los Angeles Lakers’ 115-113 victory over the Golden State Warriors — a game pitting Olympic teammates LeBron James and Stephen Curry — averaged 7.76 million viewers and peaked with about 8.32 million viewers toward the end of the contest, the league said. Those numbers represent the most-watched NBA regular season game in five years. The NBA said all five Christmas games on its schedule — San Antonio at New York in Victor Wembanyama's holiday debut, Minnesota at Dallas, Philadelphia at Boston, Denver at Phoenix and Lakers-Warriors — saw year-over-year viewership increases. Wednesday's numbers pushed NBA viewership for the season across ESPN platforms to up 4% over last season. The league also saw more than 500 million video views on its social media platforms Wednesday, a new record. For the NBA, those are all good signs amid cries that NBA viewership is hurting. “Ratings are down a bit at beginning of the season. But cable television viewership is down double digits so far this year versus last year," NBA Commissioner Adam Silver said earlier this month. “You know, we’re almost at the inflection point where people are watching more programing on streaming than they are on traditional television. And it’s a reason why for our new television deals, which we enter into next year, every game is going to be available on a streaming service.” Part of that new package of television deals that the NBA is entering into next season also increases the number of regular season games broadcast on television from 15 to 75.Safety is ‘at the core’ of TikTok, European executive says

The Washington Commanders put kicker Austin Seibert on injured reserve Tuesday, just over 48 hours since he missed an extra point that would have tied the score with 21 seconds left against Dallas. Seibert also missed a field-goal attempt and another extra point in the loss to the Cowboys. He missed the previous two games with a right hip injury but said afterward he was fine and made the decision to play. The Commanders filled that roster spot by signing running back Chris Rodriguez Jr. off their practice squad. Austin Ekeler had a concussion and Brian Robinson Jr. sprained an ankle Sunday. Story continues below video AP NFL: https://apnews.com/hub/nfl

JPEF Is An Active ETF To Shortlist, But Mind Performance Nuances And ExpensesNHL Trade Talk Prediction: Clock Ticking on Kuzmenko’s NHL CareerOklahoma State WR Da'Wain Lofton plans to enter transfer portalNo. 3 Nittany Lions relying on defensive depth in Big Ten title game and postseason run

Donald Trump is returning to the world stage. So is his trolling